217 related articles for article (PubMed ID: 25518932)
1. Itch E3 ubiquitin ligase positively regulates TGF-β signaling to EMT via Smad7 ubiquitination.
Park SH; Jung EH; Kim GY; Kim BC; Lim JH; Woo CH
Mol Cells; 2015 Jan; 38(1):20-5. PubMed ID: 25518932
[TBL] [Abstract][Full Text] [Related]
2. Smad7 Protein Interacts with Receptor-regulated Smads (R-Smads) to Inhibit Transforming Growth Factor-β (TGF-β)/Smad Signaling.
Yan X; Liao H; Cheng M; Shi X; Lin X; Feng XH; Chen YG
J Biol Chem; 2016 Jan; 291(1):382-92. PubMed ID: 26555259
[TBL] [Abstract][Full Text] [Related]
3. CD109-mediated degradation of TGF-β receptors and inhibition of TGF-β responses involve regulation of SMAD7 and Smurf2 localization and function.
Bizet AA; Tran-Khanh N; Saksena A; Liu K; Buschmann MD; Philip A
J Cell Biochem; 2012 Jan; 113(1):238-46. PubMed ID: 21898545
[TBL] [Abstract][Full Text] [Related]
4. Selective targeting of activating and inhibitory Smads by distinct WWP2 ubiquitin ligase isoforms differentially modulates TGFβ signalling and EMT.
Soond SM; Chantry A
Oncogene; 2011 May; 30(21):2451-62. PubMed ID: 21258410
[TBL] [Abstract][Full Text] [Related]
5. ASPP2 suppresses invasion and TGF-β1-induced epithelial-mesenchymal transition by inhibiting Smad7 degradation mediated by E3 ubiquitin ligase ITCH in gastric cancer.
Gen Y; Yasui K; Kitaichi T; Iwai N; Terasaki K; Dohi O; Hashimoto H; Fukui H; Inada Y; Fukui A; Jo M; Moriguchi M; Nishikawa T; Umemura A; Yamaguchi K; Konishi H; Naito Y; Itoh Y
Cancer Lett; 2017 Jul; 398():52-61. PubMed ID: 28400336
[TBL] [Abstract][Full Text] [Related]
6. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
[TBL] [Abstract][Full Text] [Related]
7. AIP4 restricts transforming growth factor-beta signaling through a ubiquitination-independent mechanism.
Lallemand F; Seo SR; Ferrand N; Pessah M; L'Hoste S; Rawadi G; Roman-Roman S; Camonis J; Atfi A
J Biol Chem; 2005 Jul; 280(30):27645-53. PubMed ID: 15946939
[TBL] [Abstract][Full Text] [Related]
8. Current perspectives on inhibitory SMAD7 in health and disease.
de Ceuninck van Capelle C; Spit M; Ten Dijke P
Crit Rev Biochem Mol Biol; 2020 Dec; 55(6):691-715. PubMed ID: 33081543
[TBL] [Abstract][Full Text] [Related]
9. Axin is a scaffold protein in TGF-beta signaling that promotes degradation of Smad7 by Arkadia.
Liu W; Rui H; Wang J; Lin S; He Y; Chen M; Li Q; Ye Z; Zhang S; Chan SC; Chen YG; Han J; Lin SC
EMBO J; 2006 Apr; 25(8):1646-58. PubMed ID: 16601693
[TBL] [Abstract][Full Text] [Related]
10. Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation.
Ebisawa T; Fukuchi M; Murakami G; Chiba T; Tanaka K; Imamura T; Miyazono K
J Biol Chem; 2001 Apr; 276(16):12477-80. PubMed ID: 11278251
[TBL] [Abstract][Full Text] [Related]
11. Regulation of TGF-beta signaling by Smad7.
Yan X; Liu Z; Chen Y
Acta Biochim Biophys Sin (Shanghai); 2009 Apr; 41(4):263-72. PubMed ID: 19352540
[TBL] [Abstract][Full Text] [Related]
12. Regulation of TGF-beta family signaling by E3 ubiquitin ligases.
Inoue Y; Imamura T
Cancer Sci; 2008 Nov; 99(11):2107-12. PubMed ID: 18808420
[TBL] [Abstract][Full Text] [Related]
13. Bardoxolone ameliorates TGF-β1-associated renal fibrosis through Nrf2/Smad7 elevation.
Song MK; Lee JH; Ryoo IG; Lee SH; Ku SK; Kwak MK
Free Radic Biol Med; 2019 Jul; 138():33-42. PubMed ID: 31059771
[TBL] [Abstract][Full Text] [Related]
14. Negative regulation of transforming growth factor-beta (TGF-beta) signaling by WW domain-containing protein 1 (WWP1).
Komuro A; Imamura T; Saitoh M; Yoshida Y; Yamori T; Miyazono K; Miyazawa K
Oncogene; 2004 Sep; 23(41):6914-23. PubMed ID: 15221015
[TBL] [Abstract][Full Text] [Related]
15. TSC-22 promotes transforming growth factor β-mediated cardiac myofibroblast differentiation by antagonizing Smad7 activity.
Yan X; Zhang J; Pan L; Wang P; Xue H; Zhang L; Gao X; Zhao X; Ning Y; Chen YG
Mol Cell Biol; 2011 Sep; 31(18):3700-9. PubMed ID: 21791611
[TBL] [Abstract][Full Text] [Related]
16. Degradation of the tumor suppressor Smad4 by WW and HECT domain ubiquitin ligases.
Morén A; Imamura T; Miyazono K; Heldin CH; Moustakas A
J Biol Chem; 2005 Jun; 280(23):22115-23. PubMed ID: 15817471
[TBL] [Abstract][Full Text] [Related]
17. RNF11 sequestration of the E3 ligase SMURF2 on membranes antagonizes SMAD7 down-regulation of transforming growth factor β signaling.
Malonis RJ; Fu W; Jelcic MJ; Thompson M; Canter BS; Tsikitis M; Esteva FJ; Sánchez I
J Biol Chem; 2017 May; 292(18):7435-7451. PubMed ID: 28292929
[TBL] [Abstract][Full Text] [Related]
18. USP26 regulates TGF-β signaling by deubiquitinating and stabilizing SMAD7.
Kit Leng Lui S; Iyengar PV; Jaynes P; Isa ZFBA; Pang B; Tan TZ; Eichhorn PJA
EMBO Rep; 2017 May; 18(5):797-808. PubMed ID: 28381482
[TBL] [Abstract][Full Text] [Related]
19. Smad7 antagonizes transforming growth factor beta signaling in the nucleus by interfering with functional Smad-DNA complex formation.
Zhang S; Fei T; Zhang L; Zhang R; Chen F; Ning Y; Han Y; Feng XH; Meng A; Chen YG
Mol Cell Biol; 2007 Jun; 27(12):4488-99. PubMed ID: 17438144
[TBL] [Abstract][Full Text] [Related]
20. VprBP mitigates TGF-β and Activin signaling by promoting Smurf1-mediated type I receptor degradation.
Li Y; Cui C; Xie F; Kiełbasa S; Mei H; van Dinther M; van Dam H; Bauer A; Zhang L; Ten Dijke P
J Mol Cell Biol; 2020 Feb; 12(2):138-151. PubMed ID: 31291647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
